loadpatents
name:-0.05146598815918
name:-0.028244972229004
name:-0.0020511150360107
Meyrueix; Remi Patent Filings

Meyrueix; Remi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Meyrueix; Remi.The latest application filed is for "oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s).".

Company Profile
0.27.38
  • Meyrueix; Remi - Lyons FR
  • Meyrueix; Remi - Lyon FR
  • Meyrueix; Remi - Le Bois Saint-Rambert FR
  • Meyrueix, Remi - Venissieux FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
Grant RE47,084 - Castan , et al. October 16, 2
2018-10-16
Composition comprising an active agent with low aqueous solubility
Grant 10,052,289 - Meyrueix , et al. August 21, 2
2018-08-21
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 10,004,693 - Castan , et al. June 26, 2
2018-06-26
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 9,814,684 - Castan , et al. November 14, 2
2017-11-14
Oral Pharmaceutical Formulation In The Form Of An Aqueous Suspension Of Microcapsules For The Modified Release Of Active Principle(s).
App 20170281558 - Castan; Catherine ;   et al.
2017-10-05
Oral Pharmaceutical Formulation In The Form Of Aqueous Suspension For Modified Release Of Active Principle(s)
App 20150374636 - Castan; Catherine ;   et al.
2015-12-31
Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s)
App 20150374635 - Castan; Catherine ;   et al.
2015-12-31
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
Grant 8,734,850 - Castan , et al. May 27, 2
2014-05-27
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
Grant 8,652,523 - Guimberteau , et al. February 18, 2
2014-02-18
Composition Comprising Interferon Alpha
App 20120294832 - Pouliquen; Gauthier ;   et al.
2012-11-22
Self-precipitating pharmaceutical formulations for the modified release of an active principle
Grant 8,236,353 - Checot , et al. August 7, 2
2012-08-07
Nanoparticles Having At Least One Active Ingredient And At Least Two Polyelectrolytes
App 20120156256 - Bonnet-Gonnet; Cecile ;   et al.
2012-06-21
Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same
Grant 8,197,850 - Castan , et al. June 12, 2
2012-06-12
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
Grant 8,101,209 - Legrand , et al. January 24, 2
2012-01-24
Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
Grant 8,084,045 - Pouliquen , et al. December 27, 2
2011-12-27
Long-acting colloidal insulin formulation and its preparation
Grant 8,017,156 - Constancis , et al. September 13, 2
2011-09-13
Oral Pharmaceutical Formulation In The Form Of An Aqueous Suspension Of Microcapsules For Modified Release Of Amoxicillin
App 20110129539 - Castan; Catherine ;   et al.
2011-06-02
Oral Pharmaceutical Formulation In The Form Of Aqueous Suspension For Modified Release Of Active Principle(s)
App 20110117205 - Castan; Catherine ;   et al.
2011-05-19
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
Grant 7,910,133 - Castan , et al. March 22, 2
2011-03-22
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
Grant 7,906,145 - Castan , et al. March 15, 2
2011-03-15
Oral pharmaceutical compositions with controlled release and prolonged absorption
Grant 7,879,362 - Castan , et al. February 1, 2
2011-02-01
Anti-misuse Microparticulate Oral Drug Form
App 20100266701 - Guimberteau; Florence ;   et al.
2010-10-21
Composition comprising an active agent with low aqueous solubility
App 20100178337 - MEYRUEIX; Remi ;   et al.
2010-07-15
Oral Medicament Based on a Proton Pump Inhibitor
App 20100068291 - CAISSE; Philippe ;   et al.
2010-03-18
Microparticle oral form useful for the modified release of nanoparticles
App 20100021549 - Meyrueix; Remi ;   et al.
2010-01-28
Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor Antagonists
App 20090311315 - Castan; Catherine ;   et al.
2009-12-17
Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising Same
App 20090220611 - Dargelas; Frederic ;   et al.
2009-09-03
Oral Pharmaceutical Form of Losartan
App 20090123536 - Castan; Catherine ;   et al.
2009-05-14
Long-acting colloidal insulin formulation and its preparation
App 20090110742 - Constancis; Alain ;   et al.
2009-04-30
Anti-Misuse Microparticulate Oral Drug Form
App 20090041838 - Guimberteau; Florence ;   et al.
2009-02-12
Self-precipitating pharmaceutical formulations for the moified release of an active principle
App 20090011028 - Checot; Frederic ;   et al.
2009-01-08
Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule Form
App 20080305160 - Guimberteau; Florence ;   et al.
2008-12-11
Antibiotic-Based Pharmaceutical Formulation in Microcapsular Form
App 20080026056 - Guimberteau; Florence ;   et al.
2008-01-31
Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic Applications
App 20070269517 - Pouliquen; Gauthier ;   et al.
2007-11-22
Pharmaceutical Formulations For The Prolonged Release Of Interleukins And Their Therapeutic Applications
App 20070218142 - Bignon; Sophie ;   et al.
2007-09-20
Oral pharmaceutical compositions with controlled release and prolonged absorption
App 20070207214 - Castan; Catherine ;   et al.
2007-09-06
Pharmaceutical formulations for the prolonged release of active principle(s) and their applications
App 20070196497 - Pouliquen; Gauthier ;   et al.
2007-08-23
Oral ribavirin pharmaceutical compositions
App 20070173464 - Guimberteau; Florence ;   et al.
2007-07-26
Oral ribavirin pharmaceutical compositions
App 20070166378 - Guimberteau; Florence ;   et al.
2007-07-19
Microcapsules with modified release of active principles with low solubility for oral delivery
App 20060275376 - Guimberteau; Florence ;   et al.
2006-12-07
Microcapsules for the delayed, controlled release of perindopril
App 20060165808 - Huet De Barochez; Bruno ;   et al.
2006-07-27
Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility
App 20060165809 - Guimberteau; Florence ;   et al.
2006-07-27
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
App 20060165807 - Castan; Catherine ;   et al.
2006-07-27
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
App 20060110463 - Castan; Catherine ;   et al.
2006-05-25
Carvedilol salts, anhydrates and/or solvate thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
App 20050196459 - Castan, Catherine ;   et al.
2005-09-08
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
App 20050175695 - Castan, Catherine ;   et al.
2005-08-11
Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles
App 20050037077 - Legrand, Valerie ;   et al.
2005-02-17
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
App 20040234601 - Legrand, Valerie ;   et al.
2004-11-25
Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
App 20040219212 - Castan, Catherine ;   et al.
2004-11-04
Novel compositions
App 20040208936 - Chorin, Roland ;   et al.
2004-10-21
Cross-linked collagenic peptide for preventing post-surgical adhesions
Grant 6,790,438 - Constancis , et al. September 14, 2
2004-09-14
Oral pharmaceutical composition with controlled release and prolonged absorption
App 20040022849 - Castan, Catherine ;   et al.
2004-02-05
Process and compositions promoting biological effectiveness of exogenous chemical substances in plants
Grant 6,500,783 - Bryson , et al. December 31, 2
2002-12-31
Process And Compositions Promoting Biological Effectiveness Of Exogenous Chemical Substances In Plants
App 20010019996 - SOULA, GERARD G. ;   et al.
2001-09-06
Composite gel microparticles as active principle carriers
Grant 6,180,141 - Lemercier , et al. January 30, 2
2001-01-30
Process and compositions promoting biological effectiveness of exogenous chemical substances in plants
Grant 6,133,199 - Soula , et al. October 17, 2
2000-10-17
Crosslinkable polymer, particularly for optical and non-linear optical use, materials or devices using same, and method for preparing said polymer
Grant 6,001,958 - Tapolsky , et al. December 14, 1
1999-12-14
Nonlinearly optically active compounds
Grant 5,535,048 - Mignani , et al. July 9, 1
1996-07-09
Thiophene-related compounds active in nonlinear optics, materials and devices containing them
Grant 5,156,774 - Leising , et al. October 20, 1
1992-10-20
Organic material active in nonlinear optics
Grant 5,075,409 - Barthelemy , et al. December 24, 1
1991-12-24
Novel nonlinearly optically active polyurethanes
Grant 4,985,528 - Mignani , et al. January 15, 1
1991-01-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed